The present invention relates to novel hepcidin antagonists, pharmaceutical compositions comprising them and the use thereof as medicaments for the use in the treatment of iron metabolism disorders, such as, in particular, iron deficiency diseases and anemias, in particular anemias in connection with chronic inflammatory diseases.
Auxiliary-Directed C(sp<sup>3</sup>
)−H Arylation by Synergistic Photoredox and Palladium Catalysis
作者:Milena L. Czyz、David W. Lupton、Anastasios Polyzos
DOI:10.1002/chem.201704045
日期:2017.10.17
Herein we describe the auxiliary‐directedarylation of unactivated C(sp3)−H bonds with aryldiazonium salts, which proceeds under synergistic photoredox and palladium catalysis. The site‐selective arylation of aliphatic amides with α‐quaternary centres is achieved with high selectivity for β‐methyl C(sp3)−H bonds. This operationally simple method is compatible with carbocyclic amides, a range of aryldiazonium
A First Example of Cobalt-Catalyzed Remote CH Functionalization of 8-Aminoquinolines Operating through a Single Electron Transfer Mechanism
作者:Christopher J. Whiteoak、Oriol Planas、Anna Company、Xavi Ribas
DOI:10.1002/adsc.201600161
日期:2016.5.19
through a single electron transfer (SET) mechanism, although requiring elevated reaction temperatures. Herein, we described the first example of a cobalt‐catalyzed remoteCH functionalization of 8‐aminoquinoline compounds operating through a SET mechanism, exemplified using a practical and mild nitration protocol. The reaction uses inexpensive cobalt nitrate hexahydrate [Co(NO3)2⋅6 H2O] as catalyst and
Acid Catalysis in the Oxidation of Substrates by Mononuclear Manganese(III)–Aqua Complexes
作者:Jisheng Zhang、Yong-Min Lee、Mi Sook Seo、Shunichi Fukuzumi、Wonwoo Nam
DOI:10.1021/acs.inorgchem.2c00430
日期:2022.5.2
metal–oxo, −hydroperoxo, −peroxo, and −superoxo complexes, in biomimetic oxidation reactions. Although metal–aqua (and metal–hydroxo) complexes have been shown to be potent oxidants in oxidation reactions, acid effects on the reactivities of metal–aqua complexes have never been investigated previously. In this study, a mononuclear manganese(III)–aqua complex, [(dpaq5NO2)MnIII(OH2)]2+ (1; dpaq5NO2 = 2-
TRIPLE SUBSTITUTED PHENANTHROLINE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE OR HAEMATOLOGICAL DISEASES OR CONDITIONS, OR CANCER
申请人:Medina Padilla Miguel
公开号:US20110306631A1
公开(公告)日:2011-12-15
The present invention relates to a new family of triple substituted phenantroline derivatives of formula (I), which are useful for the treatment or profilaxis of a neurodegenerative or haematological disease or condition or cancer, their use as a medicament, especially for treating a neurodegenerative or haematological disease or condition or cancer, and a pharmaceutical composition comprising the compounds.